Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00531661 · ClinicalTrials.gov registry record · NA
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
A NA study, sponsored by CardioMEMS.
- Completed
- Registry status
- NA
- Development phase
- 550
- Enrollment target
NCT00531661 is a NA study that has completed, run by CardioMEMS. The registered enrollment target is 550 participants.
The verdict
NCT00531661, a NA study, has completed, sponsored by CardioMEMS.
- COMPLETED
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, randomized, single-blind clinical trial conducted in the United States (US). The objective of the study is to evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.
Interventions
- DEVICE HF Pressure Measurement System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2007-09 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00531661
The ClinicalTrials.gov registry entry for NCT00531661 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioMEMS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HF Pressure Measurement System is the first listed.
NCT00531661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00531661 about?
NCT00531661 is a clinical study titled "CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients". This is a prospective, multi-center, randomized, single-blind clinical trial conducted in the United States (US). The objective of the study is to evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects su...
What is the current status of trial NCT00531661?
This trial is currently completed. It is a NA study. The enrollment target is 550 participants. The study started on 2007-09. Estimated completion is 2014-11.
What interventions are being tested in trial NCT00531661?
The interventions under investigation include: HF Pressure Measurement System (DEVICE).
Who is sponsoring clinical trial NCT00531661?
This trial is sponsored by CardioMEMS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.